Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001807359-26-000010

Director sold 17,750 shares at an average $34.38 ($610,252)

  • Director acquired 17,750 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Epperly Melissa B, · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-29 Exercise or conversion : show line 1 in the form 10b5-1 +17,750 $4.46 $79,165 34,224 D
2026-06-29 Sale : show line 2 in the form 10b5-1 −15,002 $34.32 $514,869 19,222 D
2026-06-29 Sale : show line 3 in the form 10b5-1 −2,748 $34.71 $95,383 16,474 D
Open-market sales · 17,750 sh · avg $34.38 · $610,252

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-29 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −17,750 169,166 D
Loading xslF345X06/wk-form4_1782945259.xml…